Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.77
Delayed Data
As of May 22
 +0.12 / +3.29%
Today’s Change
3.00
Today|||52-Week Range
4.69
+14.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues9.4K30.9K105.3K152.0K
 
 
 
 
 
Cost of Goods Sold26.6K32.7K44.5K59.0K
 
 
 
 
 
Depreciation And Amortization288.00289.00135.000.00
 
 
 
 
 
Operating ExpensesGross Income-17.5K-2.1K60.6K93.0K
 
 
 
 
 
General Expenses2.6M4.6M3.4M2.8M
 
 
 
 
 
Research And Development1.6M2.2M2.5M2.0M
 
 
 
 
 
Total Operating Expenses2.6M4.6M3.4M2.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.6M-4.6M-3.3M-2.7M
 
 
 
 
 
Interest Expense On Debt108.2K15.3K19.1K6.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.7M-4.6M-3.3M-2.7M
 
 
 
 
 
Net Income-2.7M-4.6M-3.3M-2.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.5M53.3M56.4M57.1M
 
 
 
 
 
Shares To Calculate EPS Diluted51.5M53.3M56.4M57.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.09-$0.06-$0.05
 
 
 
 
 
EPS Diluted-$0.05-$0.09-$0.06-$0.05